Compare Sudden Stopping and Weaning of Anticholinergics in Recurrence of OAB Symptoms
Status:
Completed
Trial end date:
2019-08-02
Target enrollment:
Participant gender:
Summary
Our study included 60 patients with idiopathic OAB and treated with solifenacin 5mg twice
daily for one month. After improvement of their condition, we divided the responders into 2
groups, group I stopped the drug suddenly, while group II underwent gradual weaning of the
drug.
Phase:
N/A
Details
Lead Sponsor:
Beni-Suef University
Treatments:
Cholinergic Antagonists Solifenacin Succinate Tin Fluorides